|
Discover the science behind Mesenchymal Stem Cells Therapy, which forms the basis of VL-PX10 and VL-P22—innovative treatments designed for Pulmonary Fibrosis in patients suffering from Long COVID. These therapies utilize exosomes derived from human umbilical cord mesenchymal stem cells (MSCs) to promote tissue repair and immune regulation. Uncover the future of regenerative medicine.
|